Deep Breathe

London, Ontario, Canada  All Canada companies → Founded 2021
Imaging AI Specialist Point-of-Care Diagnostics Specialty-Focused AI
Cardiology Critical Care Pulmonology
Radiology & Imaging AI
Venture Capital-Backed (Early Stage VC Series A upcoming) — $115K (plus a $95K prize from xTechInternational)

Products

BlineSlide
Deep Breathe Inc.
Radiology & Imaging AI
BlineSlide by Deep Breathe is an FDA-cleared AI-powered cloud service for analyzing lung ultrasound images, assisting physicians in detecting B-line artifacts and other lung conditions with high accuracy.

See all 1 product →

About Deep Breathe

Deep Breathe is a pioneering Canadian medical technology company that leverages artificial intelligence (AI) to revolutionize lung health diagnostics. The company’s core offering is an AI-powered platform designed for immediate and accurate detection of respiratory abnormalities through seamless integration with existing point-of-care ultrasound (POCUS) equipment. This innovative approach aims to significantly enhance clinical decision-making, improve patient outcomes, and streamline diagnostic workflows by providing rapid, objective interpretations of lung ultrasound images. [2, 3, 5, 8]

For physicians, Deep Breathe’s technology offers a critical advancement in accessible, radiation-free lung imaging. Their AI model autonomously assesses lung health by interpreting ultrasound artifacts, supporting the detection of various conditions including heart failure, pneumonia, occupational lung disease, and lung contusion. [15] Notably, the technology is hardware-agnostic, ensuring compatibility across diverse ultrasound platforms, thereby removing barriers to advanced lung diagnostics in a wide array of clinical environments, from emergency rooms to remote field operations. [15, 6] This capability empowers healthcare providers to deliver sophisticated lung diagnostics wherever patients are located, democratizing access to high-precision medical imaging. [11, 15]

Deep Breathe’s commitment to innovation is further demonstrated by its recent U.S. Food and Drug Administration (FDA) 510(k) clearance for its Software as a Medical Device (SaMD) that autonomously assesses lung health from ultrasound images. [15] The company’s solutions are built upon a vast, proprietary archive of expertly-annotated lung ultrasound images, enabling the development of robust deep learning algorithms. [3, 8] This positions Deep Breathe as a leader in transforming lung diagnostics, making high-quality care more readily available and efficient.

Focus Areas

Lung diagnostics lung ultrasound AI-powered medical imaging respiratory diseases point-of-care ultrasound pneumothorax pneumonia heart failure occupational lung diseases lung contusions military applications aerospace veterinary medicine

Business Intelligence

Key InvestorsMAP Equity Investco, U.S. Army xTech ($100,000 prize winner), Federal Economic Development Agency for Southern Ontario (FedDev)
PartnershipsUniversity of Waterloo (co-op students), leading ultrasound manufacturers (potential), TechAlliance
TechnologyAI-driven software as a medical device (SaMD), deep learning algorithms, computer vision classifiers, integrates with point-of-care ultrasound equipment, hardware-agnostic, runs locally on Android and iOS devices without connectivity, cloud-native approach for data security
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Comprehensive Lung Diagnostics
Deep Breathe specializes in advanced diagnostics for a wide array of respiratory diseases, including pneumonia, pneumothorax, heart failure (as it relates to lung congestion), occupational lung diseases, and lung contusions. Their solutions aim to provide rapid and accurate assessments across various critical conditions.
AI-Powered Medical Imaging & Ultrasound
Leveraging cutting-edge AI, Deep Breathe enhances lung ultrasound capabilities, transforming raw imaging data into actionable insights. This AI integration significantly improves diagnostic accuracy and efficiency, particularly for complex lung pathologies.
Point-of-Care (POC) Excellence
A core focus is on point-of-care ultrasound, enabling physicians to perform rapid, bedside diagnostics. This reduces the need for patient transport, speeds up decision-making, and allows for immediate intervention, crucial in emergency and critical care settings.
Versatile & Specialized Applications
Beyond traditional clinical environments, Deep Breathe's technology is tailored for demanding fields such as military applications, aerospace medicine, and veterinary medicine, demonstrating robustness and adaptability in diverse, high-stakes scenarios.
Key Differentiators
Their unique blend of lung ultrasound with advanced AI interpretation, coupled with a strong emphasis on point-of-care diagnostics, sets Deep Breathe apart. This combination offers unparalleled speed, accuracy, and accessibility in lung assessment, reducing reliance on more complex or radiation-emitting imaging modalities.
Technology Stack
The technology stack primarily revolves around advanced ultrasound transducers, proprietary AI/Machine Learning algorithms for real-time image analysis and pattern recognition, and intuitive software interfaces designed for rapid interpretation and seamless integration into clinical workflows.
Physician Tip

For physicians, Deep Breathe's solutions offer several compelling advantages. The AI-powered lung ultrasound significantly reduces the learning curve for ultrasound interpretation, making it accessible to a broader range of practitioners. The point-of-care nature allows for immediate diagnostic answers, streamlining patient management and potentially reducing hospital stays. It's a non-invasive, radiation-free alternative that can be rapidly deployed in various settings, from the ER to remote clinics, enhancing diagnostic confidence and improving patient outcomes through quicker, more informed decisions.

Deep Breathe's systems are designed for seamless integration with existing hospital infrastructure, including Electronic Health Records (EHR) and Picture Archiving and Communication Systems (PACS), ensuring that diagnostic data is easily accessible and incorporated into the patient's comprehensive medical record.

Products by Deep Breathe

1 product in the directory

BlineSlide
Deep Breathe Inc.
Radiology & Imaging AI
BlineSlide by Deep Breathe is an FDA-cleared AI-powered cloud service for analyzing lung ultrasound images, assisting physicians in detecting B-line artifacts and other lung conditions with high accuracy.

Reviews & Opinions

No web reviews on file yet for Deep Breathe. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Deep Breathe.

Loading videos...

Videos load interactively. If none appear, search YouTube for Deep Breathe →

View all on YouTube

Press & Coverage

EIN Presswire
Deep Breathe Secures FDA Clearance for Groundbreaking AI Lung Ultrasound Diagnostic
Deep Breathe Inc. received U.S. FDA 510(k) clearance for its AI-powered Software as a Medical Device (SaMD) that autonomously assesses lung health from ultrasound images, marking a significant milestone in lung diagnostics.
2025-10
London Free Press
London tech firm eyes overseas growth, takes part in NATO exercises
Deep Breathe, a London-based technology business, is participating in NATO exercises for six months, aiming to expand its AI and ultrasound technology for detecting lung and torso issues into new overseas markets after already gaining traction with the U.S. and Canadian military.
2025-12
Schulich School of Medicine & Dentistry, Western University
Health startups receive boost from Ontario Life Sciences Fund
Deep Breathe was awarded up to $500,000 from Ontario's Life Sciences Innovation Fund to advance its AI-powered lung ultrasound applications, aiming to make lung health diagnostics universally accessible.
2025-06
Newswire.ca
Canadian Medical AI Company - Deep Breathe - Wins First Place in US Army's xTechInternational 2024 Competition, Outpacing Over 100 Global Competitors
Deep Breathe won the 2024 xTechInternational competition hosted by the U.S. Army, recognized for its AI-powered diagnostic solutions that automate and enhance the interpretation of portable lung ultrasound images.
2024-09
CBC News
London medical startup attracts international attention with AI ultrasound tech
Deep Breathe, a London-based medical technology company, is gaining international recognition for its AI program that interprets lung ultrasounds on a phone, recently winning the xTechInternational competition hosted by the U.S. Army.
2024-09
London Free Press
London ultrasound firm among local companies splitting $240K in FedDev cash
Deep Breathe received funding from the Federal Economic Development Agency for Southern Ontario to research new business opportunities, including using its ultrasound technology to detect internal bleeding.
2024-12
The SaaS News
Deep Breathe Closes Funding Round - The SaaS News
Deep Breathe, a Canadian medical technology company, closed a significant external financing round led by MAP Equity Investco to expand R&D and accelerate regulatory approval for its AI-powered lung ultrasound interpretation technology.
2023-02
ResearchGate
Artificial Intelligence Interpretation of Point-of-Care Lung Ultrasound in Microgravity
This article discusses the application of artificial intelligence for interpreting point-of-care lung ultrasound in microgravity environments, with authors from Western University and Deep Breathe.
2026-07

Frequently Asked Questions

Deep Breathe's technology combines lung ultrasound with advanced AI to diagnose various respiratory conditions, including pneumothorax, pneumonia, and features of heart failure. Key products include PneumoLens, an AI model for lung sliding detection, and the A/B Line Classifier, which differentiates normal lung tissue from patterns associated with conditions like heart failure or pneumonia.
Deep Breathe revolutionizes point-of-care lung diagnostics by offering portable, radiation-free, and automated lung imaging that can be used anywhere, from ambulances to nursing homes. This accessibility and efficiency can lead to rapid and accurate diagnoses, potentially improving patient outcomes and streamlining diagnostic workflows compared to traditional, often costly and time-consuming, chest X-rays.
Deep Breathe's PneumoLens AI model for lung sliding is currently undergoing regulatory validation. The company is committed to safety and compliance, developing its solutions according to clinical software best practices and aiming for universal accessibility with cutting-edge, radiation-free solutions.
Deep Breathe's vision extends to making automated lung imaging integral to diverse settings such as military operations, aerospace missions, and emergency response teams, significantly improving global health outcomes. The company also offers AlveolAI-vet, an AI model specifically designed for normal versus abnormal lung detection in large and companion animal veterinary environments.
Deep Breathe's technology is designed to be vendor-agnostic, working seamlessly across all ultrasound hardware, allowing for easy integration with existing infrastructure. The company actively pursues strategic partnerships with leading ultrasound manufacturers and other key industries to continually advance its technology and expand its reach.
Deep Breathe's long-term vision is to transform lung health diagnostics by making automated, radiation-free lung imaging universally accessible to both healthcare providers and laypersons. The company, founded by world-renowned point-of-care ultrasound expert Dr. Rob Arntfield, demonstrates stability through its team of diverse experts, multiple patents filed, and ongoing regulatory validation of its products.
While specific pricing models are not publicly detailed, Deep Breathe's mission emphasizes making lung imaging universally accessible and cost-effective by leveraging portable lung ultrasound and AI. This approach aims to reduce reliance on more expensive and radiation-exposing traditional methods like chest X-rays, potentially leading to significant cost savings and improved efficiency in diagnostic workflows.

Investors

Who's funded Deep Breathe.

Related Companies

Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]

HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]

Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]

Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.